Insight into the molecular mechanisms underlying enhanced gonadotropin hormone receptor activity in polycystic ovarian syndrome

被引：0
|
作者：
Owens, L. [1 ]
Lerner, A. [1 ]
Sposini, S. [1 ]
Christopoulos, G. [1 ]
Liyanage, M. [1 ]
Islam, R. [1 ]
Lavery, S. [1 ]
Tsui, V [1 ]
Hardy, K. [1 ]
Franks, S. [1 ]
Hanyaloglu, A. [1 ]
机构：
[1] Imperial Coll London, Inst Reprod & Dev Biol, London, England
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC5
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [21] Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropin-releasing hormone in women with the polycystic ovary syndrome
    Dafopoulos, Konstantinos
    Venetis, Christos
    Pournaras, Spyros
    Kallitsaris, Athanasios
    Messinis, Ioannis E.
    FERTILITY AND STERILITY, 2009, 92 (04) : 1378 - 1380
  • [22] Role of growth hormone in polycystic ovarian syndrome
    Morales, AJ
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1997, 15 (02): : 177 - 182
  • [23] Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome
    Gill, S
    Taylor, AE
    Martin, KA
    Welt, CK
    Adams, JM
    Hall, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06): : 2428 - 2436
  • [24] BENEFITS OF CONTINUOUS PHYSIOLOGICAL PULSATILE GONADOTROPIN-RELEASING-HORMONE THERAPY IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
    CORENTHAL, L
    VONHAGEN, S
    LARKINS, D
    IBRAHIM, J
    SANTORO, N
    FERTILITY AND STERILITY, 1994, 61 (06) : 1027 - 1033
  • [25] Gonadotropin Activity during Early Folliculogenesis and Implications for Polycystic Ovarian Syndrome and Premature Ovarian Insufficiency: A Narrative Review
    Longobardi, Salvatore
    Klinger, Francesca Gioia
    Zheng, Wenjing
    Campitiello, Maria Rosaria
    D'Hooghe, Thomas
    La Marca, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [26] GONADOTROPIN-RELEASING HORMONE RECEPTOR AUTOANTIBODY ACTIVITY IN POLYCYSTIC OVARY SYNDROME - STABILITY OF AUTOANTIBODY LEVELS OVER TIME.
    Weedin, E.
    Burks, H.
    Yu, X.
    Aston, C.
    Dubaut, J. P.
    Kem, D. C.
    Craig, L. B.
    FERTILITY AND STERILITY, 2018, 110 (04) : E113 - E113
  • [27] Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome
    Scarfo, Giorgia
    Daniele, Simona
    Fusi, Jonathan
    Gesi, Marco
    Martini, Claudia
    Franzoni, Ferdinando
    Cela, Vito
    Artini, Paolo Giovanni
    BIOMEDICINES, 2022, 10 (06)
  • [28] LOW-DOSE GONADOTROPIN THERAPY IN POLYCYSTIC OVARIAN SYNDROME
    FRANKS, S
    HAMILTONFAIRLEY, D
    SAGLE, M
    POLSON, D
    KIDDY, D
    WATSON, H
    WHITE, D
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 687 : 301 - 304
  • [29] GONADOTROPIN-SECRETION IN POLYCYSTIC OVARIAN SYNDROME AND RELATED DISEASES
    MILLS, TM
    MAHESH, VB
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1986, 4 (02): : 109 - 113
  • [30] Effects of gonadotropin-releasing hormone agonist and antagonist on ovarian activity in a mouse model for polycystic ovary
    Singh, Padmasana
    Srivastava, Raj Kamal
    Krishna, Amitabh
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 163 : 35 - 44
12345